Showing 5031-5040 of 21466 results for "".
- Racket Sports Rank Highest for Pediatric Myopia Controlhttps://reachmd.com/news/racket-sports-rank-highest-for-pediatric-myopia-control/2487959/Key Takeaways Across 16 randomized controlled trials involving 9,084 children and adolescents, racket sports appeared to rank highest versus control for slowing axial elongation, with MD −0.30 mm and SUCRA 94.9%. Increased outdoor time ranked second for axial length,
- Childhood Trauma, Resilience and Adult Outcomes in SMI Familieshttps://reachmd.com/news/childhood-trauma-resilience-and-adult-outcomes-in-smi-families/2487941/Key Takeaways Among adults who grew up with a parent meeting the study definition of severe mental illness, higher self-efficacy and resilience and lower morbidity were independently associated with better quality of life in the adjusted model Poorer adult social fun
- Swimming Program Reduced Disability in Chronic Low Back Painhttps://reachmd.com/news/swimming-program-reduced-disability-in-chronic-low-back-pain/2487943/Key Takeaways In the EduSwim randomized controlled trial, adults with chronic low back pain who received individualized swimming plus education had lower disability at 8 weeks than adults who received education alone. The trial randomized 76 adults aged 26-74 years,
- Machine Learning Flags Post-Trauma Musculoskeletal Risk Subgrouphttps://reachmd.com/news/machine-learning-flags-post-trauma-musculoskeletal-risk-subgroup/2487945/Key Takeaways Sparse group factor analysis identified a distinct subgroup of 125 injured nonamputee participants with worse musculoskeletal outcomes and generated a follow-up hypothesis linking head injury to later deterioration in hypothesis-generating, noncausal terms.
- Non-Light-Based Energy Devices Continue to Expand the Aesthetic Treatment Landscapehttps://reachmd.com/news/non-light-based-energy-devices-continue-to-expand-the-aesthetic-treatment-landscape/2487934/A growing body of evidence supports the use of non-light-based energy devices as minimally invasive treatment options for a wide range of aesthetic concerns, according to a newly published review in the Journal of Craniofacial Surgery. The review summarizes current evidence surrounding r
- ACTN2 Variants in HCM Show Distinct Protein Effectshttps://reachmd.com/news/actn2-variants-in-hcm-show-distinct-protein-effects/2487926/Key Takeaways A 2026 Nature Communications study linked 17 ACTN2 variants to hypertrophic cardiomyopathy. The reported ACTN2 variants altered alpha-actinin-2 through differing effects on protein stability, aggregation, and molecular interactions.
- Psoriasis Disease Activity Linked to Specific Sleep Dysfunctionhttps://reachmd.com/news/psoriasis-disease-activity-linked-to-specific-sleep-dysfunction/2487935/Key Takeaways PASI 10 or higher was associated with worse sleep latency and greater daytime dysfunction than lower disease activity. Global PSQI scores did not significantly differ between the severity groups, indicating a domain-specific pattern.
- Perioperative Brain Bundle Linked to Net Savingshttps://reachmd.com/news/perioperative-brain-bundle-linked-to-net-savings/2487928/Key Takeaways In a single-center Swiss hospital model, implementing a perioperative brain healthcare bundle was associated with 300 fewer PACU-detected postoperative delirium events, 421 hospital days saved, and CHF 389 523 in net savings within 12 months (95% CI 159 209 to 6
- Study Reports High Patient Satisfaction with Scar-Free Neck Rejuvenation Techniquehttps://reachmd.com/news/study-reports-high-patient-satisfaction-with-scar-free-neck-rejuvenation-technique/2487925/A novel anterior neck rejuvenation technique may provide meaningful improvements in cervical contour while eliminating the need for periauricular incisions, according to a retrospective case series published online ahead of print in Aesthetic Plastic Surgery. Anterior-Only
- Comparative Weight Loss With CagriSema, Semaglutide, Cagrilintide, and Tirzepatidehttps://reachmd.com/news/comparative-weight-loss-with-cagrisema-semaglutide-cagrilintide-and-tirzepatide/2487906/Key Takeaways Tirzepatide 15 mg and CagriSema showed the strongest overall weight-loss signals in this indirect comparison of randomized trials. At the at least 20% weight-loss threshold, CagriSema ranked first and tirzepatide 15 mg ranked second.